CAMBRIDGE, Mass., June 16 /CNW/ -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will webcast its corporate presentations at NASDAQ's 17th Investor Program on Wednesday, June 21, 2006 at 2:45 p.m. British Summer Time (BST) (9:45 a.m. EDT) and at the Piper Jaffray London Healthcare Conference on Thursday, June 22, 2006 at 9:20 a.m. BST (4:20 a.m. EDT). The presentations will be delivered by John Alam, M.D., Executive Vice President, Medicines Development and Chief Medical Officer of Vertex. The presentations will be webcast live and may be accessed by visiting the Vertex website at http://www.vrtx.com. A replay of the webcasts will also be available on the Company's website for two weeks following the presentations. To access the webcasts, go to Vertex's website and select the 'NASDAQ 17th Annual Investor Program' or the 'Piper Jaffray London Healthcare Conference' from the 'Events & Presentations' page. To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast. About Vertex Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is principally focused on viral diseases, inflammation, autoimmune diseases and cancer. In collaboration with GlaxoSmithKline, Vertex co-promotes the HIV protease inhibitor, Lexiva. Lexiva is a registered trademark of the GlaxoSmithKline group of companies. Vertex's press releases are available at http://www.vrtx.com. Vertex Contact: Lora Pike, Manager, Investor Relations, (617) 444-6755